Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing,
inflammatory skin disease. The course of the disease may be complicated by bacterial or …

Objective To determine the effects of age related, structured educational programmes on the
management of moderate to severe atopic dermatitis in childhood and adolescence. Design …

Background Lumacaftor and ivacaftor combination treatment showed efficacy in patients
aged 12 years or older with cystic fibrosis homozygous for F508del-cystic fibrosis …

Cystic fibrosis patients suffer from chronic lung infection and inflammation due to the
secretion of viscous sputum. Sputum viscosity is caused by extracellular DNA, some of …

Atopic dermatitis (AD) in childhood is a common disease with prevalence rates as high as
20%. Its early onset in infancy and its chronic relapsing course puts a special burden on …

Rationale: Lower respiratory tract infection with Pseudomonas aeruginosa (PA) is
associated with increased morbidity in patients with cystic fibrosis (CF). Current treatment …

MATERIALS AND METHODS The German Task Force on Education programmes for Atopic
Dermatitis (AGNES) for children, youths and parents was founded in 2000.(www …

OBJECTIVE: The objective of this study was to prove training-specific effects in children with
atopic dermatitis (AD) and their parents concerning coping with the disease after their …

This guideline is an update from August 2020 the S2k‐guideline “Atopic dermatitis”
published in 2015. The reason for updating this chapter of the guideline were the current …

Background The PEPITES (Peanut EPIT Efficacy and Safety) trial, a 12-month randomized
controlled study of children with peanut allergy and 4 to 11 years old, previously reported the …